Related by context. All words. (Click for frequent words.) 72 Genotypic 70 allele frequencies 69 NNRTI resistance 69 phenotypic 68 genotypes 68 orthologs 67 linkage disequilibrium 67 bacterial genomes 67 #S rRNA gene 67 epistasis 67 VKORC1 67 heterozygotes 67 genotype 67 Phenotypic 67 QTLs 67 genotypic resistance 67 differentially expressed genes 67 A. thaliana 67 genomewide 66 allelic 65 immunohistochemical 65 miRNA expression 65 nucleotide substitutions 65 splice variants 65 transgene expression 65 IL#B 65 differential gene expression 65 H#K#me# 65 body louse genome 64 etiologic 64 IgG antibody 64 HCV replicon 64 HER2 expression 64 quasispecies 64 HLA DRB1 * 64 rs# [004] 64 quantitative trait loci 64 missense mutations 64 K#N 64 microsatellite markers 64 germline mutations 64 CCL#L# 64 mRNA expression 64 proteomes 64 univariate 64 favorable pharmacokinetic profile 64 FLT3 64 K ras mutations 64 introgression 64 #S rRNA 64 RRM1 64 heritable traits 63 serologic 63 indels 63 Bonferroni correction 63 Clusterin 63 pharmacodynamic markers 63 subcellular localization 63 sequenced genomes 63 transcriptomic 63 APOE genotype 63 virulence genes 63 CC genotype 63 polymorphisms 63 viral kinetics 63 gene loci 63 Genotypes 63 allelic variation 63 CYP#C# [002] 63 serum biomarkers 63 pharmacodynamic PD 63 plasma lipid 63 paternally inherited 63 phylogenetic analyzes 63 phenotypic variation 63 UGT#A# 63 virological response 63 ABCB1 63 APTIMA HPV 63 qRT PCR 63 heterologous expression 63 haplotypes 63 virologic responses 63 virological 63 bivariate analysis 63 homozygote 63 genetic polymorphisms 63 vitro experiments 63 KRAS mutations 62 seropositivity 62 Candida species 62 sequence homology 62 clinicopathological 62 HIV RNA 62 tyrosine phosphorylation 62 mammographic density 62 allele frequency 62 quantitative PCR 62 QTL mapping 62 transcriptomes 62 genetic polymorphism 62 mtDNA mutations 62 C. albicans 62 vitro assay 62 perilipin 62 tumorigenicity 62 mRNA transcripts 62 CYP#D# gene 62 #S rDNA 62 ELISPOT 62 Poisson regression 62 MRSA isolates 62 rs# [001] 62 histopathological 62 microarray experiments 62 PTPN# 62 gene polymorphisms 62 RT qPCR 62 HBV genotype 62 gene rearrangements 62 silico prediction 62 #S rRNA genes 62 mitochondrial DNA mtDNA 62 inbred strains 62 p# biomarker 62 genotype phenotype 62 CYP#D# genotype 62 DNA demethylation 62 Univariate 62 multivariate Cox 62 mitochondrial genomes 62 chlamydial 62 alleles 62 Phylogenetic analysis 62 5 HTTLPR 62 methylated DNA 62 N. gonorrhoeae 62 homozygosity 62 homozygotes 62 neutralizing antibody 62 ortholog 62 convergent validity 62 phylogenetic analysis 62 GABRA2 61 HIV HCV coinfected 61 SNP rs# [002] 61 gene expression profiles 61 KRAS mutation 61 multiple logistic regression 61 epistatic 61 immunological responses 61 cDNA microarray 61 intraobserver 61 plasma pharmacokinetics 61 Meta analyzes 61 transcriptional profiling 61 VNTR 61 HLA DR 61 genetic variability 61 M. pneumoniae 61 chemosensitivity 61 haematopoietic 61 gene locus 61 HBsAg 61 prostate cancer CaP 61 Cytogenetic 61 Multiple logistic regression 61 DRD2 61 NPM1 61 metabolite concentrations 61 bivariate 61 genetic loci 61 PFGE 61 phenotypic expression 61 coexpression 61 multivariate logistic regression 61 peripheral blood mononuclear 61 miR #a [001] 61 Leydig cell 61 B. longum 61 Multivariate logistic regression 61 histological subtype 61 MLH1 61 phenotypic traits 61 EGFR TKIs 61 replicon 61 conditional logistic regression 61 situ hybridization 61 Typhi 61 metabolomic profiles 61 granulocyte 61 methylation patterns 61 mutant allele 61 breast cancer subtypes 61 immunoblotting 61 Supplementary Table 61 Multimeric 61 K ras 61 paralogs 61 multigenic 61 transcriptome 61 microarray gene expression 61 genotyped 61 microbiota 61 prognostic indicators 61 airway responsiveness 61 Immunohistochemical analysis 61 apolipoproteins 61 prostate carcinoma 61 multivariate analyzes 61 Haptoglobin 61 JAK2 V#F 61 immunofluorescence staining 61 5 hmC 61 phenotyping 61 serological 61 PITX2 61 cis regulatory 61 alkaline phosphatase ALP 61 Symadex 61 hemagglutination inhibition 61 differentially expressed proteins 61 pharmacodynamic biomarkers 61 PCR RFLP 61 GPx 61 genetic variants associated 61 ANOVA 61 p# activation 61 nonparametric 61 K RAS 60 phenotypes 60 nucleoside 60 co receptor tropism 60 heterozygous 60 tumor subtypes 60 haplotype map 60 Neisseria gonorrhoeae 60 microRNA expression 60 C#BL/#J 60 genetic relatedness 60 immunostaining 60 Gag polymorphisms 60 chromosomal regions 60 Logistic regression 60 lactate dehydrogenase 60 logistic regression analysis 60 GSTP1 60 S. cerevisiae 60 primate genomes 60 S/GSK# 60 transcriptional regulation 60 pharmacokinetic PK 60 mutational 60 Histopathologic 60 dose proportionality 60 BRAF V#E mutation 60 prognostic markers 60 transcriptome sequencing 60 TTR gene 60 EGFR mutations 60 variant allele 60 immunomodulation 60 methylenetetrahydrofolate reductase 60 clinico pathological 60 C#Y 60 syngeneic 60 interferon IFN 60 Kruskal Wallis test 60 Aspergillus nidulans 60 scintigraphic 60 logistic regressions 60 T#I [002] 60 fluoroquinolone resistance 60 prospectively defined 60 ceftazidime 60 T. brucei 60 univariate analysis 60 substrate specificity 60 IPAH 60 Leydig cells 60 quantitative RT PCR 60 genomic alterations 60 serum lipid levels 60 TOP2A 60 galiximab 60 pharmacokinetic interactions 60 multigene 60 indel 60 posttranslational modifications 60 P. falciparum 60 morphologic 60 interobserver 60 nucleotide sequence 60 variant rs# 60 hematological parameters 60 HLA B# 60 herpesviruses 60 Pharmacokinetic PK 60 imatinib therapy 60 immunofluorescence microscopy 60 Multivariate analysis 60 HRCT 60 PK PD 60 fig. S1 60 antitumor effect 60 K#R [002] 60 diploid 60 somatic mutations 60 undetectable HBV DNA 60 potent inhibition 60 transcriptional activation 60 serum leptin 60 NOD mouse 60 relapsed MM 60 proteomic analyzes 60 antiangiogenic agents 60 cytogenetic 60 nucleotide substitution 60 P. falciparum parasites 60 logistic regression analyzes 60 multivariate regression analysis 60 quantitative PCR qPCR 60 aCGH 60 protein tyrosine phosphatase 60 multivariable analysis 60 methyltransferase 60 adipogenic 60 International HapMap Project 60 virologic 60 KLF4 60 Immunohistochemistry 60 M. genitalium 60 genomic 60 proteolytic cleavage 60 Non inferiority 60 micafungin 60 orthologous genes 60 cDNAs 60 ncRNA 60 predictive biomarker 59 logistic regression model 59 microsatellite loci 59 immunohistochemical analysis 59 C. trachomatis 59 haplotype 59 Randomized trials 59 fluconazole resistant 59 phenotypic characteristics 59 microRNA profiling 59 ChIP chip 59 CYP#D# 59 seronegative 59 logistic regression 59 #p# [003] 59 genes CYP#C# 59 phylogenetic 59 amplicons 59 ovarian carcinoma 59 delafloxacin 59 AST ALT 59 mitochondrial proteins 59 Sgk1 59 CISH 59 murine models 59 ELISpot 59 prognostic significance 59 HSCT 59 lamivudine resistant 59 siRNA mediated 59 KRAS BRAF 59 Mendelian 59 heterozygosity 59 rifamycins 59 Genetic variation 59 SNP rs# [001] 59 Cyclin E 59 pharmacokinetics PK 59 KRAS status 59 ERBB2 59 evolvability 59 covariate 59 S. maltophilia 59 serum lipid 59 Bacteroides 59 promoter methylation 59 viremia 59 IFN α 59 haplogroups 59 prion strains 59 Arabidopsis genes 59 HCV infected 59 malaria parasite genome 59 genomic rearrangement 59 Transcriptome 59 RFLP 59 array CGH 59 PCa 59 metabolome 59 C. neoformans 59 TPMT 59 mtDNA 59 HLA alleles 59 microRNA biomarkers 59 resistant isolates 59 transcriptomics 59 Immunohistochemical 59 codon usage 59 genomic profiling 59 pharmacodynamic parameters 59 HBV vaccine 59 xenograft models 59 ribosomal proteins 59 pharmacokinetic characteristics 59 C. jejuni 59 microsatellite instability 59 ploidy 59 NRTI resistance 59 UGT#A# * 59 polymorphism 59 clade B 59 TGFBR1 * 6A 59 MC1R gene 59 ADRB2 59 flavopiridol 59 phenotype 59 clusterin 59 microdeletions 59 V#F mutation 59 aneuploid 59 functional polymorphism 59 synteny 59 serum antibody 59 inactivating mutations 59 tumor necrosis 59 antiviral efficacy 59 IFN gamma 59 μmol L 59 gambiae 59 susceptibility loci 59 HLA B 59 solithromycin 59 Estrogen Receptor 59 siRNA knockdown 59 retrospective cohort 59 CDK inhibitor 59 pharmacogenetic testing 59 CORE OM 59 mutated K ras 59 CYP #D# 59 tumor biopsies 59 posaconazole 59 nucleoside analogues 59 nested PCR 59 APOL1 59 gene expression profiling 59 electrophysiologic 59 bactericidal activity 59 immunohistochemistry IHC 59 virus HBV 59 chi squared 59 Apobec3 59 XmAb# 59 BRAF mutation 59 interferon γ 59 phylogenetically 59 immunohistochemical staining 59 E. histolytica 59 serum PTH 59 genotype 1a 59 lactis 59 transgenic mouse models 59 pancreatic adenocarcinoma 59 G allele 59 L. pneumophila 59 transfected 59 ENMD # 59 meta regression 59 orthologous 59 δ 59 TIMP 1 59 ultrastructural 59 fluoroquinolone resistant 59 APOE e4 59 miRNA expression profiles 59 DGGE 59 proband 59 transgenic rats 59 Leptospira 59 comparative genomic analysis 59 pharmacodynamic 59 meta analytic 59 glycolytic 59 genomic biomarkers 59 airway hyperresponsiveness 59 caspofungin 59 ± SEM 59 nanomolar 58 Histologic 58 causal variants 58 NS4A 58 cytochrome b 58 serum concentrations 58 biomarker identification 58 lymph node metastasis 58 pairwise comparisons 58 ritonavir boosted 58 Sanger sequencing 58 logistic regression models 58 molecular biomarker 58 spontaneous mutations 58 locoregional 58 semiquantitative 58 H pylori 58 DHPLC 58 frameshift mutation 58 inbred mouse 58 karyotype 58 metabolomic profiling 58 ChIP seq 58 FUS1 58 Western blotting 58 antimicrobial susceptibility 58 prognostic marker 58 KRAS mutation status 58 Anopheles gambiae 58 SLC#A# [002] 58 urothelial carcinoma 58 TNFalpha 58 viral tropism 58 autosomal 58 HBeAg 58 chronicity 58 Treg cell 58 epigenetic mechanisms 58 mutant alleles 58 prognostically 58 urine dipstick 58 virologic failure 58 serum antibodies 58 pharmacodynamic properties 58 HOXB# 58 karyotypes 58 Plasmodium 58 multiple linear regression 58 induced sputum 58 Plasmodium falciparum 58 molecular biomarkers 58 bronchoalveolar lavage 58 antiviral potency 58 miRNA sequences 58 MTT assay 58 inhibin 58 HepG2 cells 58 preclinically 58 modifier genes 58 polyploidy 58 HER2 overexpression 58 maternally inherited 58 intact parathyroid hormone 58 comparative genomic hybridization 58 MET amplification 58 heterozygote 58 hierarchical clustering 58 hENT1 58 Immunohistochemical staining 58 F FDG PET 58 pharmacodynamic endpoints 58 NSCLC tumors 58 CagA 58 cagA 58 drug metabolizing enzymes 58 EGFR mutation status 58 parasitaemia 58 Kaplan Meier curve 58 heterologous 58 immunoglobulin G 58 mammalian genomes 58 eukaryotic genomes 58 pharmacokinetic PK profile 58 germline 58 histopathologic 58 CALGB 58 lupus anticoagulant 58 polygenic 58 enterococcal 58 CCR5 antagonist 58 follicular fluid 58 neutralizing antibody responses 58 ZNF# 58 gene expression patterns 58 MTHFR 58 somatic mutation 58 monozygotic twins 58 MSH2 58 chimp genomes 58 PIK3CA 58 vitro cytotoxicity 58 genes differentially expressed 58 genomic variation 58 methylation markers 58 Reynolds Risk Score 58 Amino acid 58 elvucitabine 58 molecular determinants 58 familial aggregation 58 Borrelia 58 PCR assays 58 ANCOVA 58 proteomic analysis 58 Her2/neu 58 heritable variation 58 mutational analysis 58 Chlamydia trachomatis 58 MGUS 58 polyploid 58 X chromosome inactivation 58 ImmuKnow 58 seroprevalence 58 linkage disequilibrium LD 58 P. patens 58 linear pharmacokinetics 58 immunochemical 58 monogenic 58 ESR1 58 immunocompetent 58 tumor histology 58 Jhdm2a 58 antiapoptotic 58 HCV genotypes 58 CDK4 58 KRAS oncogene 58 enfuvirtide 58 coinfected patients 58 vivax 58 Pearson correlation coefficients 58 colorectal tumor 58 genomic loci 58 E. faecalis 58 LRAT 58 gene amplification 58 JAK2 inhibitors 58 pleiotropic effects 58 EQ 5D 58 hydroxylase 58 mosaicism 58 hERG 58 busulfan 58 hematopoietic cancers 58 mycobacterial 58 homologues 58 Kaplan Meier analysis 58 splice junctions 58 Enterococcus faecalis 58 rRNA 58 5 hydroxymethylcytosine 58 Supplementary Fig 58 EBV infection 58 maize genome 58 Alkaline Phosphatase 58 hMG 58 microbial genome 58 spontaneous mutation 58 pharmacogenetic 58 chlamydial infection 58 ^ sup #m 58 transcriptome analysis 58 T#M 58 TACI mutations 58 TRAIL induced apoptosis 58 BCR ABL mutations 58 COX2 58 C#BL 6 mice 58 hypermethylated 58 BMAL1 58 APTIVUS r 58 sensitivity specificity 58 K ras gene 58 effector function 58 autism susceptibility genes 58 circadian clock genes 58 outcrossing 58 p# biomarkers 58 mutant BRAF 58 Haplotype 58 Mutational 58 nucleosome positioning 58 reverse transcriptase inhibitors 58 antibody titer 58 genes encoding 58 non nucleoside 58 colon carcinoma 58 cystatin 58 immunoblot 58 CANCIDAS 58 Phylogenetic analyzes 58 univariate analyzes 58 stem cell pluripotency 58 Alu elements 58 HERmark assay 58 PCR assay 58 reverse transcriptase polymerase chain 58 CCX# 58 pomalidomide 58 exomes 58 gastric carcinomas 58 coding exons 58 CDKN2A 58 vasopressin receptor 58 BRCA2 mutation carriers 58 mitochondrial gene 58 viral isolates 58 outbred 58 chromosomal rearrangement 58 BEXXAR Therapeutic Regimen 58 thiopurine 58 glycosylated 58 #F FDG PET 58 constitutively expressed 58 KIAA# 57 histone modification 57 genomic DNA 57 serum HBV DNA 57 replicase 57 RNAi mediated 57 ABL1 57 PCR amplified 57 assay detects 57 t# c# CLA 57 histocompatibility 57 Genetic Variation 57 S. aureus isolates 57 Subgroup analysis 57 Sequencing Systems 57 PCR amplification 57 HbF 57 alanine aminotransferase ALT 57 NNRTI resistant virus 57 Caenorhabditis 57 receptor subtypes 57 catechol O methyltransferase 57 mediated inhibition 57 luciferase reporter 57 plasma folate 57 vimentin 57 Foxp3 57 XL# inhibits 57 TRIM5 57 prion infection 57 VIPR2 57 nitrotyrosine 57 #q#.# [001] 57 mitochondrial genome 57 oseltamivir resistance 57 KRAS gene 57 PBMCs 57 PKCi 57 HBeAg negative chronic hepatitis 57 Plasmodium infection 57 superinfection 57 tigecycline 57 Secondary efficacy endpoints 57 FGFR3 57 PCA3 57 constitutively active 57 probands 57 Lp PLA 2 57 IgG1 57 HER3 57 hTERT 57 Pharmacodynamic 57 cytosolic 57 anti JCV antibodies 57 Antigenic 57 cytidine 57 RT PCR assay 57 eTag assays 57 cyclin E 57 trastuzumab Herceptin ® 57 multivariable Cox 57 FGFs 57 serovar 57 multiplexed assays 57 FGFR2 57 EGFR mutation 57 amino acid substitutions 57 monozygotic 57 generalized vitiligo 57 BVDV 57 A3 adenosine receptor 57 VeriStrat 57 cDNA 57 seliciclib 57 proton MR spectroscopy 57 pharmacokinetic studies 57 activating mutations 57 pathophysiological 57 radezolid 57 potent antitumor activity 57 tipranavir ritonavir 57 rs# [002] 57 CYP#C# [001] 57 H. influenzae 57 HLA DQ2 57 Prochlorococcus 57 intergenic regions 57 BACcel ™ system 57 mGluR5 antagonist 57 bacterial virulence 57 clinicopathological features 57 putative biomarkers 57 clades 57 cytotoxicity assays 57 epitope mapping 57 thrombophilia 57 specific IgE 57 penetrance 57 PITX2 methylation 57 TOP2A gene 57 genomewide association studies 57 TRAF1 C5 57 CD8 responses 57 metazoan 57 IGFBP 57 cDNA libraries 57 intestinal microflora 57 antiviral activity 57 histone modifications 57 histone acetylation 57 GFT# 57 bFGF 57 monophyletic 57 Drosophila genome 57 T. vaginalis 57 chromatin immunoprecipitation 57 hepatic fibrosis 57 PALB2 57 probiotic Lactobacillus 57 HIF PH inhibitors 57 cMET 57 histone deacetylases 57 chromosomal aberrations 57 fungal genomes 57 Wilcoxon rank sum 57 lymphoblastoid cell lines 57 BRAF mutations 57 novel VDA molecule 57 Subgroup analyzes 57 metaanalysis 57 beta actin 57 MYH9 gene 57 hemoglobin Hb 57 antiangiogenic activity 57 rFSH 57 Mutation Analysis 57 SLITRK1 57 GSTM1 gene 57 RNA Seq 57 Linear regression 57 HPV-#/# 57 LTBI 57 miRs 57 Pharmacokinetic 57 single nucleotide polymorphism 57 M#V mutation 57 NMIBC 57 Fig. 3a 57 glutamic acid decarboxylase 57 selenium supplementation 57 cystatin C 57 Xanafide 57 toxicogenomic 57 BAC clones 57 JAK2 mutation 57 prospective multicentre 57 N Myc 57 neoplastic 57 racemic baclofen 57 nonclinical studies 57 prostate cancer PCa 57 somatostatin 57 DNA methyltransferases 57 causative mutations 57 B7 H3 57 S. enterica 57 p# antigen 57 receptor inhibitor 57 metagenomes 57 IL 1ß 57 ribosomal RNA rRNA 57 antiandrogens 57 inhibin B 57 lenalidomide dexamethasone 57 globin genes 57 isoenzyme 57 MDRD equation 57 florbetaben 57 PON1 gene 57 epigenetic regulation 57 multidrug resistance 57 gene expression 57 LRRK2 gene 57 immunomodulatory effects 57 post translational modifications 57 metabolomic 57 ABCB1 gene 57 refractory chronic lymphocytic 57 nucleoside naive 57 variance ANOVA 57 baseline LDH 57 IgA deficiency 57 hemagglutination 57 synthetic lethality 57 BRAF V#E 57 splice variant 57 E#F# 57 outer membrane proteins 57 IL #E 57 protein isoforms 57 cytopathic 57 dinucleotide 57 MDRD 57 T#M mutation 57 proteolysis 57 protease inhibitor PI 57 CIN2 + 57 EphB4 57 loci 57 R5 tropic 57 massively parallel sequencing 57 echocardiographic parameters 57 microglial 57 surrogate markers 57 HBeAg negative patients 57 NSABP B 57 COMT genotype 57 IGFBP2 57 malignant transformation 57 pleiotropic 57 transfected cells 57 immunodominant 57 coinfection 57 MDR1 57 Cathepsin B 57 statistical significance p 57 N acetyltransferase 57 intronic 57 uricase 57 gene expression microarray 57 tipifarnib 57 mTOR inhibitors 57 NXL# 57 C. difficile toxins 57 activin 57 ncRNAs 57 PON1 57 CDH1 57 Pharmacokinetics PK 57 #ß 57 #q#.# [002] 57 LB# [003] 57 pharmacodynamics 57 fluorescence intensity 57 multivariable logistic regression 57 immunostimulatory effects 57 viral genomes 57 proteome 57 hormone receptor status 57 amino acid substitution 57 Virological 57 leukotriene B4 57 5 HT2A 57 SSc 57 β1 57 gastric adenocarcinoma 57 LPA gene 57 microbiologic 57 ertapenem 57 ALK mutations 57 Mass Spectrometry MS 57 abnormal cytology 57 mechanistic studies 57 clinicopathologic 57 hA# 57 hyperinsulinemic euglycemic clamp 57 gene expression microarrays 57 plasma lipoprotein 57 RQ PCR 57 preclinical efficacy 57 P. ovale 57 eIF4E 57 NNRTIs 57 Prognostic 57 tropism testing 57 oncogenic transformation 57 Fig. 3b 57 phylogenetic relationships 57 sCD# 57 MHC genes 57 IFN alpha